Owlstone snags $15 mln
UK-based Owlstone Medical Ltd, a developer of a breathalyzer for disease, has raised $15 million in funding. Horizons Venture and Aviva Ventures led the round.
5 March 2018•5 mins read
UK-based Owlstone Medical Ltd, a developer of a breathalyzer for disease, has raised $15 million in funding. Horizons Venture and Aviva Ventures led the round.
